Regeneron Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Regeneron Pharmaceuticals patents 704 in total
| Status | Patent |
|---|---|
Grant | Utility: Humanized T cell co-receptor mice Filling date: 12 Sep 2025 Issue date: 3 Nov 2020 |
Application | Utility: METHOD OF TREATING OSTEOARTHRITIS WITH AN ANTIBODY TO NGF Filling date: 12 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING JUVENILE IDIOPATHIC ARTHRITIS Filling date: 12 Sep 2025 Issue date: 29 Oct 2020 |
Grant | Utility: Methods of treating inflammatory conditions Filling date: 12 Sep 2025 Issue date: 27 Oct 2020 |
Application | Utility: HUMAN ANTIBODIES TO PD-1 Filling date: 12 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: METHODS FOR TREATING EOSINOPHILIC ESOPHAGITIS BY ADMINISTERING AN IL-4R INHIBITOR Filling date: 12 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: IDENTIFICATION OF HOST CELL PROTEINS Filling date: 12 Sep 2025 Issue date: 22 Oct 2020 |
Grant | Utility: Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof Filling date: 12 Sep 2025 Issue date: 20 Oct 2020 |
Application | Utility: Isolating Cells Expressing Secreted Proteins Filling date: 12 Sep 2025 Issue date: 15 Oct 2020 |
Application | Utility: Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Antigen-Binding Molecules that Bind MUC16 and CD3, and Uses Thereof Filling date: 12 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR INSERTION OF ANTIBODY CODING SEQUENCES INTO A SAFE HARBOR LOCUS Filling date: 12 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: METHODS FOR SCARLESS INTRODUCTION OF TARGETED MODIFICATIONS INTO TARGETING VECTORS Filling date: 12 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: NON-HUMAN ANIMALS COMPRISING A HUMANIZED COAGULATION FACTOR 12 LOCUS Filling date: 12 Sep 2025 Issue date: 8 Oct 2020 |
Grant | Utility: Human antibodies to Bet v 1 and methods of use thereof Filling date: 12 Sep 2025 Issue date: 6 Oct 2020 |
Grant | Utility: Methods and compositions for targeted genetic modifications and methods of use Filling date: 12 Sep 2025 Issue date: 6 Oct 2020 |
Application | Utility: System and Method for Characterizing Protein Dimerization Filling date: 12 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: DEVICES AND METHODS FOR PRECISION DOSE DELIVERY Filling date: 12 Sep 2025 Issue date: 1 Oct 2020 |
Grant | Utility: Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments Filling date: 12 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: V.sub.L antigen binding proteins exhibiting distinct binding characteristics Filling date: 12 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: HSD17B13 variants and uses thereof Filling date: 12 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Genetically modified non-human animals and methods of use thereof Filling date: 12 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Humanized M-CSF mice Filling date: 12 Sep 2025 Issue date: 29 Sep 2020 |
Application | Utility: METHODS FOR ANALYSIS OF VIRAL CAPSID PROTEIN COMPOSITION Filling date: 12 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: METHODS FOR TREATING ALLERGY AND ENHANCING ALLERGEN-SPECIFIC IMMUNOTHERAPY BY ADMINISTERING AN IL-4R INHIBITOR Filling date: 12 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: EGFR x CD28 MULTISPECIFIC ANTIBODIES Filling date: 12 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: Stabilized Formulations Containing Anti-IL-33 Antibodies Filling date: 12 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: Treatment Of Increased Lipid Levels With Sterol Regulatory Element Binding Protein Cleavage-Activating Protein (SCAP) Inhibitors Filling date: 12 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: Treatment Of Increased Lipid Levels With Sterol Regulatory Element Binding Transcription Factor 1 (SREBF1) Inhibitors Filling date: 12 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: CRISPR/CAS SCREENING PLATFORM TO IDENTIFY GENETIC MODIFIERS OF TAU SEEDING OR AGGREGATION Filling date: 12 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: CRISPR/CAS DROPOUT SCREENING PLATFORM TO REVEAL GENETIC VULNERABILITIES ASSOCIATED WITH TAU AGGREGATION Filling date: 12 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: METHODS AND SYSTEMS FOR CRISPR SELECTION Filling date: 12 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: Treatment Of Hyperglycemia With Solute Carrier Family 39 Member 5 (SLC39A5) Inhibitors Filling date: 12 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: Multivalent Antigen-Binding Proteins Filling date: 12 Sep 2025 Issue date: 24 Sep 2020 |
Grant | Utility: Genetically modified major histocompatibility complex animals Filling date: 12 Sep 2025 Issue date: 22 Sep 2020 |
Grant | Utility: Non-human animals having a hexanucleotide repeat expansion in a C9ORF72 locus Filling date: 12 Sep 2025 Issue date: 22 Sep 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR THE TARGETED MODIFICATION OF A GENOME Filling date: 12 Sep 2025 Issue date: 17 Sep 2020 |
Application | Utility: LOSS OF FUNCTION RODENT MODEL OF SOLUTE CARRIER 39 MEMBER 5 Filling date: 12 Sep 2025 Issue date: 17 Sep 2020 |
Application | Utility: NON-HUMAN ANIMALS HAVING HUMANIZED FC-GAMMA RECEPTORS Filling date: 12 Sep 2025 Issue date: 17 Sep 2020 |
Grant | Utility: IL-33 antagonists and uses thereof Filling date: 12 Sep 2025 Issue date: 15 Sep 2020 |
Grant | Utility: Anti-STEAP2 antibody drug conjugates, and compositions and uses thereof Filling date: 12 Sep 2025 Issue date: 15 Sep 2020 |
Grant | Utility: Methods for reducing or eliminating the need for lipoprotein apheresis in patients with hyperlipidemia by administering alirocumab Filling date: 12 Sep 2025 Issue date: 15 Sep 2020 |
Application | Utility: HUMANIZED NON-HUMAN ANIMALS WITH RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN LOCI Filling date: 12 Sep 2025 Issue date: 10 Sep 2020 |
Application | Utility: Human Serum Albumin in Formulations Filling date: 12 Sep 2025 Issue date: 10 Sep 2020 |
Application | Utility: IL-4/IL-13 PATHWAY INHIBITORS FOR ENHANCED EFFICACY IN TREATING CANCER Filling date: 12 Sep 2025 Issue date: 10 Sep 2020 |
Grant | Utility: Humanized model of kidney and liver disorders Filling date: 12 Sep 2025 Issue date: 8 Sep 2020 |
Application | Utility: Non-Human Animals Expressing Humanized CD3 Complex Filling date: 12 Sep 2025 Issue date: 3 Sep 2020 |
Application | Utility: Restricted Immunoglobulin Heavy Chain Mice Filling date: 12 Sep 2025 Issue date: 3 Sep 2020 |
Application | Utility: Anti-ErbB3 Antibodies and Uses Thereof Filling date: 12 Sep 2025 Issue date: 3 Sep 2020 |
Application | Utility: BIOLOGICALLY ACTIVE MOLECULES, CONJUGATES THEREOF, AND THERAPEUTIC USES Filling date: 12 Sep 2025 Issue date: 3 Sep 2020 |
Grant | Utility: Rotatable surgical table Filling date: 12 Sep 2025 Issue date: 1 Sep 2020 |
Showing 350 to 400 of 704 patents.